These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30243622)

  • 1. Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.
    Kunzmann AT; Cañadas Garre M; Thrift AP; McMenamin ÚC; Johnston BT; Cardwell CR; Anderson LA; Spence AD; Lagergren J; Xie SH; Smyth LJ; McKnight AJ; Coleman HG
    Gastroenterology; 2019 Jan; 156(1):43-45. PubMed ID: 30243622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Dighe SG; Chen J; Yan L; He Q; Gharahkhani P; Onstad L; Levine DM; Palles C; Ye W; Gammon MD; Iyer PG; Anderson LA; Liu G; Wu AH; Dai JY; Chow WH; Risch HA; Lagergren J; Shaheen NJ; Bernstein L; Corley DA; Prenen H; deCaestecker J; MacDonald D; Moayyedi P; Barr H; Love SB; Chegwidden L; Attwood S; Watson P; Harrison R; Ott K; Moebus S; Venerito M; Lang H; Mayershofer R; Knapp M; Veits L; Gerges C; Weismüller J; Gockel I; Vashist Y; Nöthen MM; Izbicki JR; Manner H; Neuhaus H; Rösch T; Böhmer AC; Hölscher AH; Anders M; Pech O; Schumacher B; Schmidt C; Schmidt T; Noder T; Lorenz D; Vieth M; May A; Hess T; Kreuser N; Becker J; Ell C; Ambrosone CB; Moysich KB; MacGregor S; Tomlinson I; Whiteman DC; Jankowski J; Schumacher J; Vaughan TL; Madeleine MM; Hardie LJ; Buas MF
    Carcinogenesis; 2021 Apr; 42(3):369-377. PubMed ID: 33300568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational subgroups for oesophageal adenocarcinoma.
    Burki TK
    Lancet Oncol; 2016 Oct; 17(10):e426. PubMed ID: 27641478
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic variants in Barrett's esophagus and esophageal adenocarcinoma: a literature review.
    Callahan ZM; Shi Z; Su B; Xu J; Ujiki M
    Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30888413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.
    Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
    Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma.
    Kunzmann AT; Thrift AP; Cardwell CR; Lagergren J; Xie S; Johnston BT; Anderson LA; Busby J; McMenamin ÚC; Spence AD; Coleman HG
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1229-1236.e4. PubMed ID: 29559360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.
    Ek WE; Levine DM; D'Amato M; Pedersen NL; Magnusson PK; Bresso F; Onstad LE; Schmidt PT; Törnblom H; Nordenstedt H; Romero Y; ; Chow WH; Murray LJ; Gammon MD; Liu G; Bernstein L; Casson AG; Risch HA; Shaheen NJ; Bird NC; Reid BJ; Corley DA; Hardie LJ; Ye W; Wu AH; Zucchelli M; Spector TD; Hysi P; Vaughan TL; Whiteman DC; MacGregor S;
    J Natl Cancer Inst; 2013 Nov; 105(22):1711-8. PubMed ID: 24168968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic biomarkers in esophageal cancer.
    Kaz AM; Grady WM
    Cancer Lett; 2014 Jan; 342(2):193-9. PubMed ID: 22406828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.
    Buas MF; Onstad L; Levine DM; Risch HA; Chow WH; Liu G; Fitzgerald RC; Bernstein L; Ye W; Bird NC; Romero Y; Casson AG; Corley DA; Shaheen NJ; Wu AH; Gammon MD; Reid BJ; Hardie LJ; Peters U; Whiteman DC; Vaughan TL
    PLoS One; 2015; 10(6):e0128617. PubMed ID: 26039359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.
    Li X; Paulson TG; Galipeau PC; Sanchez CA; Liu K; Kuhner MK; Maley CC; Self SG; Vaughan TL; Reid BJ; Blount PL
    Cancer Prev Res (Phila); 2015 Sep; 8(9):845-56. PubMed ID: 26130253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer may share genetic predisposition with esophageal squamous cell carcinoma in Chinese populations.
    Yao L; Yu F; Mao Y; Wang T; Qi Q; Ding H; Wang J; Ma H; Dai J; Zhang G; Jin G
    J Hum Genet; 2018 Nov; 63(11):1159-1168. PubMed ID: 30202044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of loci of functional relevance to Barrett's esophagus and esophageal adenocarcinoma: Cross-referencing of expression quantitative trait loci data from disease-relevant tissues with genetic association data.
    Schröder J; Schüller V; May A; Gerges C; Anders M; Becker J; Hess T; Kreuser N; Thieme R; Ludwig KU; Noder T; Venerito M; Veits L; Schmidt T; Fuchs C; Izbicki JR; Hölscher AH; Dakkak D; Jansen-Winkeln B; Moulla Y; Lyros O; Niebisch S; Mehdorn M; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Mangold E; Nöthen MM; Moebus S; Knapp M; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J; Böhmer AC
    PLoS One; 2019; 14(12):e0227072. PubMed ID: 31891614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies.
    Böhmer AC; Hecker J; Schröder J; Gharahkhani P; May A; Gerges C; Anders M; Becker J; Hess T; Kreuser N; Thieme R; Noder T; Venerito M; Veits L; Schmidt T; Fuchs C; Izbicki JR; Hölscher AH; Dietrich A; Moulla Y; Lyros O; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Moebus S; Knapp M; Neuhaus H; Rösch T; Ell C; Nöthen MM; Whiteman DC; Tomlinson I; Jankowski J; Fitzgerald RC; Palles C; Vaughan TL; Gockel I; Thrift AP; Fier H; Schumacher J
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):427-433. PubMed ID: 31748258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma.
    di Martino E; Hardie LJ; Wild CP; Gong YY; Olliver JR; Gough MD; Bird NC
    Genet Med; 2007 Jun; 9(6):341-7. PubMed ID: 17575500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk.
    Lee E; Stram DO; Ek WE; Onstad LE; MacGregor S; Gharahkhani P; Ye W; Lagergren J; Shaheen NJ; Murray LJ; Hardie LJ; Gammon MD; Chow WH; Risch HA; Corley DA; Levine DM; Whiteman DC; Bernstein L; Bird NC; Vaughan TL; Wu AH
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1801-3. PubMed ID: 26364162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
    Bobryshev YV; Orekhov AN; Chistiakov DA
    Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes.
    Varghese S; Newton R; Ross-Innes CS; Lao-Sirieix P; Krishnadath KK; O'Donovan M; Novelli M; Wernisch L; Bergman J; Fitzgerald RC
    Gastroenterology; 2015 Nov; 149(6):1511-1518.e5. PubMed ID: 26248086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.